Drug:
Reaction: MALIGNANT NEOPLASM PROGRESSION
20250101 - 20251231
No. 1101 - 1200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1101 | 24935856 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1102 | 24935868 |
US |
2 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1103 | 24935881 |
US |
1 | |
Malignant neoplasm progression, Metastases to lung, Metastases to liver, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 1104 | 24935896 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, DALTEPARIN SODIUM, DUTASTERIDE, AMLODIPINE, TELMISARTAN, MESALAMINE, LINAGLIPTIN AND METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, |
||||
| 1105 | 24935908 |
US |
2 | |
Malignant neoplasm progression, Fatigue, Dysphonia, Diarrhoea, Dyspepsia, Hyperkeratosis, Heavy menstrual bleeding, Urinary tract infection, Oral pain, Off label use, |
||||
CABOZANTINIB, FAMOTIDINE, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE, |
||||
| 1106 | 24935909 |
US |
2 | |
Malignant neoplasm progression, Drug ineffective, Off label use, |
||||
CABOZANTINIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, GABAPENTIN, LACTULOSE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE AND PRILOCAINE, METHADONE, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, OXYCODONE, FAMOTIDINE, POLYETHYLENE GLYCOL, SENNOSIDES, |
||||
| 1107 | 24935924 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1108 | 24935926 |
US |
1 | |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 1109 | 24935947 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, CABOZANTINIB, SUNITINIB MALATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 1110 | 24935950 |
US |
74 | 2 |
Haemorrhage, Septic shock, Limb mass, Clostridium difficile colitis, Malignant neoplasm progression, Acute kidney injury, Gastrointestinal disorder, Inappropriate schedule of product administration, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, |
||||
| 1111 | 24935953 |
JP |
84 | 1 |
Malignant neoplasm progression, Rash, Proteinuria, Blood creatinine increased, Therapy partial responder, Treatment noncompliance, Inappropriate schedule of product administration, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ROSUVASTATIN, LANSOPRAZOLE, AMLODIPINE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, SITAGLIPTIN, |
||||
| 1112 | 24935954 |
US |
81 | 2 |
Malignant neoplasm progression, Nausea, Blood pressure increased, Fatigue, Diarrhoea, Taste disorder, Decreased appetite, Stomatitis, Headache, Hepatic enzyme increased, Poor quality sleep, Unevaluable event, Dry mouth, Laboratory test abnormal, Product dose omission issue, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, VALSARTAN, AMLODIPINE, ISOSORBIDE DINITRATE, METOPROLOL TARTRATE, METOPROLOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NITROGLYCERIN, LATANOPROST, BRINZOLAMIDE/BRIMONIDINE TARTRATE, |
||||
| 1113 | 24935960 |
US |
65 | 1 |
Malignant neoplasm progression, Mucosal inflammation, Dizziness, Blood pressure increased, Fatigue, Weight decreased, Tongue blistering, Depressed mood, Nasopharyngitis, Hypophagia, Dehydration, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, PEMBROLIZUMAB, LOSARTAN, AMLODIPINE, GLIMEPIRIDE, OXYCODONE, |
||||
| 1114 | 24935963 |
US |
54 | 2 |
Malignant neoplasm progression, Alopecia, Fatigue, Dry skin, Pain in extremity, Muscle spasms, Tongue discomfort, Acne, Contusion, Tongue disorder, Inappropriate schedule of product administration, Off label use, |
||||
CABOZANTINIB, EVEROLIMUS, EVEROLIMUS TABLETS, MODAFINIL, PREDNISONE, THYROID, PORCINE, FUROSEMIDE, |
||||
| 1115 | 24935971 |
AE |
61 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1116 | 24935975 |
TH |
74 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1117 | 24935998 |
CZ |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1118 | 24936040 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1119 | 24936051 |
AT |
52 | 1 |
Malignant neoplasm progression, Metastases to eye, |
||||
CABOZANTINIB, LENVATINIB, PEMBROLIZUMAB, |
||||
| 1120 | 24936059 |
US |
1 | |
Malignant neoplasm progression, Fatigue, Insomnia, Sinusitis, Odynophagia, Oropharyngeal pain, Off label use, |
||||
CABOZANTINIB, STANDARDIZED SENNA CONCENTRATE, MORPHINE, |
||||
| 1121 | 24936067 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, CABOZANTINIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, BENZTROPINE, CARVEDILOL, CLOPIDOGREL, FISH OIL, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, QUETIAPINE, DIVALPROEX SODIUM, |
||||
| 1122 | 24936072 |
AT |
58 | 2 |
Malignant neoplasm progression, Osteonecrosis of jaw, |
||||
CABOZANTINIB, |
||||
| 1123 | 24936081 |
AU |
0 | 2 |
Malignant neoplasm progression, Proteinuria, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, METHADONE, |
||||
| 1124 | 24936087 |
US |
2 | |
Malignant neoplasm progression, Therapy non-responder, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 1125 | 24936089 |
US |
1 | |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 1126 | 24936095 |
RS |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1127 | 24936097 |
US |
69 | 1 |
Malignant neoplasm progression, Off label use, |
||||
CABOZANTINIB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TAMSULOSIN HYDROCHLORIDE, DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG, DOCUSATE SODIUM, SENNOSIDES, DOCUSATE SODIUM, 50 MG SENNOSIDES, 8.6 MG, SENNOSIDES AND DOCUSATE SODIUM, PANCRELIPASE, |
||||
| 1128 | 24936100 |
US |
1 | |
Malignant neoplasm progression, Off label use, |
||||
CABOZANTINIB, |
||||
| 1129 | 24936101 |
LB |
64 | 1 |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 1130 | 24936121 |
RS |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1131 | 24936122 |
RS |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1132 | 24936128 |
US |
2 | |
Malignant neoplasm progression, Off label use, |
||||
CABOZANTINIB, |
||||
| 1133 | 24936148 |
US |
32 | 2 |
Malignant neoplasm progression, Inappropriate schedule of product administration, Product prescribing issue, Off label use, |
||||
CABOZANTINIB, RIBOCICLIB, |
||||
| 1134 | 24936154 |
RS |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1135 | 24936157 |
GB |
58 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1136 | 24936158 |
RS |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1137 | 24936159 |
RS |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1138 | 24936161 |
DE |
34 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 1139 | 24936178 |
US |
2 | |
Malignant neoplasm progression, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 1140 | 24936193 |
US |
1 | |
Malignant neoplasm progression, Off label use, |
||||
CABOZANTINIB, |
||||
| 1141 | 24936194 |
BE |
||
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 1142 | 24936212 |
CA |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, FOLIC ACID, DARBEPOETIN ALFA, PANTOPRAZOLE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CEFADROXIL, METOPROLOL TARTRATE, METOPROLOL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LORAZEPAM, SODIUM FUSIDATE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 1143 | 24936221 |
US |
||
Malignant neoplasm progression, Drug ineffective, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 1144 | 24936237 |
JP |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, IPILIMUMAB, NIVOLUMAB, |
||||
| 1145 | 24936260 |
DE |
60 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 1146 | 24936261 |
CO |
59 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1147 | 24936262 |
JP |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, IPILIMUMAB, NIVOLUMAB, |
||||
| 1148 | 24936263 |
US |
75 | 1 |
Vomiting, Nausea, Dehydration, Diarrhoea, Malignant neoplasm progression, Asthenia, Headache, Dizziness, Dysphonia, Pruritus, Abnormal loss of weight, Decreased appetite, Urinary tract infection, Gait disturbance, Muscular weakness, Radiculopathy, Fall, Blood pressure decreased, Fatigue, Back pain, Inappropriate schedule of product administration, Cholelithiasis, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, NIVOLUMAB, NIVOLUMAB, CARVEDILOL, CLOPIDOGREL, CLOPIDOGREL BISULFATE, PANTOPRAZOLE SODIUM, TAMSULOSIN HYDROCHLORIDE, APIXABAN, ATORVASTATIN CALCIUM, SERTRALINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GABAPENTIN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, PANTOPRAZOLE, SERTRALINE HYDROCHLORIDE, ZOLPIDEM TARTRATE, LEVOTHYROXINE SODIUM, METHYLPREDNISOLONE, |
||||
| 1149 | 24936264 |
CO |
60 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1150 | 24936269 |
JP |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, IPILIMUMAB, NIVOLUMAB, AXITINIB, |
||||
| 1151 | 24936274 |
US |
1 | |
Malignant neoplasm progression, Abdominal discomfort, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 1152 | 24936281 |
LB |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1153 | 24936283 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, ERGOCALCIFEROL, |
||||
| 1154 | 24936285 |
CO |
72 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1155 | 24936296 |
CA |
2 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, LEVOTHYROXINE SODIUM, METHADONE, |
||||
| 1156 | 24936298 |
DE |
82 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 1157 | 24936300 |
DE |
28 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 1158 | 24936301 |
CO |
60 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1159 | 24936306 |
DE |
64 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 1160 | 24936310 |
IT |
||
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 1161 | 24936313 |
IT |
||
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 1162 | 24936314 |
IT |
||
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 1163 | 24936315 |
PL |
47 | |
Malignant neoplasm progression, Alanine aminotransferase increased, Aspartate aminotransferase increased, Therapy partial responder, |
||||
CABOZANTINIB, CABOZANTINIB, NIVOLUMAB, NIVOLUMAB, |
||||
| 1164 | 24936316 |
US |
68 | 1 |
Malignant neoplasm progression, Metastases to liver, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 1165 | 24936317 |
PL |
53 | 1 |
Malignant neoplasm progression, Hypothyroidism, Renal impairment, Palmar-plantar erythrodysaesthesia syndrome, Diarrhoea, |
||||
CABOZANTINIB, AMLODIPINE, |
||||
| 1166 | 24936319 |
DE |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 1167 | 24936324 |
US |
1 | |
Malignant neoplasm progression, Diarrhoea, |
||||
CABOZANTINIB, CABOZANTINIB, ALLOPURINOL, AMLODIPINE AND OLMESARTAN MEDOXOMIL, AAMLODIPINE AND OLMESARTAN MEDOXOMIL, BUDESONIDE, FENOFIBRATE, LISINOPRIL, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LEVOTHYROXINE SODIUM, |
||||
| 1168 | 24936327 |
CO |
65 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1169 | 24936328 |
CO |
64 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1170 | 24936329 |
CO |
72 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1171 | 24936332 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, PANTOPRAZOLE, AMLODIPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LEVOTHYROXINE SODIUM, BUPROPION HYDROCHLORIDE, BUPROPION, ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM, ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA ALBA, CALENDULA OFFICINALIS, CHAMOMILLA, CHERRY PLUM, CLEMATIS, COLOCYNTHIS, DULCAMARA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS, MILLEFOLIUM, RHUS TOXICODENDRON, ROCK ROSE, STAR OF BETHLEHEM, SULPHUR, SYMPHYTUM OFFICINALE, VERATRUM ALBUM, ACONITUM NAPELLUS,APIS MELLIFICA,ARNICA MONTANA,ARSENICUM ALBUM,BELLADONNA,BELLIS PERENNIS,BRYONIA,CALENDULA OFFICINALIS,CHAMOMILLA,CHERRY PLUM,CLEMATIS VITALBA,COLOCYNTHIS,COMFREY,DULCAMARA LIGNOSA,ECHINACEA ANGUSTIFOLIA,ECHINACEA PURPUREA,EUPATORIUM PERFOLIATUM,FERRUM PHOSPHORICUM,HAMAMELIS VIRGINIANA,HISTAMINUM,HYPERICUM PERFORATUM,IMPATIENS GLANDULIFERA,LEDUM PALUSTRE,MENTHA PIPERITA,MILLEFOLIUM,ORNITHOGALUM UMBELLATUM,PLANTAGO MAJOR,RHUS TOXICODENDRON,ROCKROSE,SULPHUR,VERATRUM ALBUM,VERBASCUM THAPSUS, ALFALFA, ANTIMONIUM CRUDUM, AVENA SATIVA, BERBERIS VULGARIS, CAJUPUTUM, CARBO ANIMALIS, CARBO VEGETABILIS, CHELIDONIUM MAJUS, FEL TAURI, GENTIANA LUTEA, GLYCYRRHIZA GLABRA, ILLICIUM ANISATUM, INDOLUM, KALI CARBONICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, NUX VOMICA, PANCREATINUM, PEPSINUM, RAPHANUS SATIVUS, RHAMNUS PURSHIANA, SKATOLUM, ALLIUM SATIVUM, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CARBO VEGETABILIS, FERRUM IODATUM, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, PHOSPHORICUM ACIDUM, URTICA URENS, AVENA SATIVA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COFFEA CRUDA, ENGLISH OAK, ESCHSCHOLTZIA CALIFORNICA, EUROPEAN HORNBEAM, FICUS CARICA, HUMULUS LUPULUS, IGNATIA AMARA, IMPATIENS GLANDULIFERA, KALI PHOSPHORICUM, KALI SILICATUM, MELISSA OFFICINALIS, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, PYRENEES STAR OF BETHLEHEM, ROCKROSE, SUS SCROFA PARASYMPATHETIC NERVE, PINEAL GLAND, SYMPATHETIC NERVE, VALERIANA OFFICINALIS, VERBENA OFFICINALIS, ZINCUM VALERIANICUM, ADRENALINUM, AETHUSA CYNAPIUM, AGNUS CASTUS, ALFALFA, ARGENTUM NITRICUM, AURUM METALLICUM, AVENA SATIVA, CERATOSTIGMA WILLMOTTIANUM FLOWER, CHERRY PLUM FLOWER, DAMIANA, EUROPEAN ASPEN FLOWER, EUROPEAN HORNBEAM FLOWER, GORSE FLOWER, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, NATRUM MURIATICUM, PASSIFLORA INCARNATA, ROSA CANINA FLOWER, SEPIA, SWEET CHESTNUT FLOWER, THYROIDINUM, WILD MUSTARD FLOWER, BELLADONNA, BLATTA ORIENTALIS, COCCUS CACTI, CORALLIUM RUBRUM, CUPRUM METALLICUM, DROSERA ROTUNDIFOLIA, ECHINACEA ANGUSTIFOLIA, HEDERA HELIX, HYDRASTIS CANADENSIS, IPECACUANHA, KALI NITRICUM, LAC VACCINUM, LOBELIA INFLATA, PASSIFLORA INCARNATA, PERTUSSINUM, SAMBUCUS NIGRA, THYMUS SERPYLLUM, VALERIANA OFFICINALIS, BALSAMUM PERUVIANUM, BORAX, BRYONIA, CALCAREA ACETICA, COCCUS CACTI, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPHORBIUM OFFICINARUM, EUPHRASIA OFFICINALIS, HISTAMINUM HYDROCHLORICUM, IPECACUANHA, KALI BICHROMICUM, LUFFA OPERCULATA, MERCURIUS CYANATUS, MERCURIUS DULCIS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, PANCREATINUM, SAMBUCUS NIGRA, SANGUINARINUM NITRICUM, SAPONARIA OFFICINALIS, ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS, ACONITUM NAPELLUS, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BELLADONNA, BRYONIA, CHERRY PLUM, CLEMATIS VITALBA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPATORIUM PERFOLIATUM, EUROPEAN OLIVE, FERRUM PHOSPHORICUM, GENTIANA LUTEA, IMPATIENS GLANDULIFERA, INFLUENZA A VIRUS, LACHESIS MUTUS, LUFFA OPERCULATA, ORNITHOGALUM UMBELLATUM, PHOSPHORUS, ROCKROSE, SARCOLACTICUM ACIDUM, VERATRUM ALBUM, YELLOW JASMINE, ARISTOLOCHIA MILHOMENS, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA OFFICINALIS, CARBO VEGETABILIS, CHAMOMILLA, CHERRY PLUM FLOWER, CLEMATIS VITALBA FLOWER, ECHINACEA ANGUSTIFOLIA, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA FLOWER, LACHESIS MUTUS, MILLEFOLIUM, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE FLOWER, RUTA GRAVEOLENS, SARCOLACTICUM ACIDUM, SULPHUR IODATUM, SYMPHYTUM OFFICINALE, VERATRUM ALBUM, ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COLOCYNTHIS, DULCAMARA LIGNOSA, ECHINACEA, EUPATORIUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA, LEDUM PALUSTRE, MENTHA PIPERITA, MILLEFOLIUM, PLANTAGO MAJOR, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE, SULFUR, COMFREY, VERATRUM ALBUM, VERBASCUM THAPSUS, ACETICUM ACIDUM, ADRENALINUM, AMERICAN GINSENG, ARNICA MONTANA, BALSAMUM PERUVIANUM, BOS TAURUS PITUITARUM POSTERIUM, CHERRY PLUM FLOWER, CHININUM ARSENICOSUM, CINCHONA OFFICINALIS, CLEMATIS VITALBA FLOWER, DAMIANA, EUROPEAN HORNBEAM FLOWER, EUROPEAN OLIVE FLOWER, GLYCYRRHIZA GLABRA, IMPATIENS GLANDULIFERA FLOWER, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, PYRENEES STAR OF BETHLEHEM, ROCKROSE FLOWER, SELENIUM METALLICUM, THYROIDINUM, |
||||
| 1172 | 24936333 |
DE |
||
Malignant neoplasm progression, Hypertension, Rash, Fatigue, Mucosal inflammation, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 1173 | 24936334 |
CO |
74 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 1174 | 24936593 |
US |
||
Malignant neoplasm progression, Drug ineffective, |
||||
OSIMERTINIB, |
||||
| 1175 | 24936824 |
US |
2 | |
Neutropenia, Hormone receptor positive HER2 negative breast cancer, Malignant neoplasm progression, Metastases to bone, Off label use, |
||||
DENOSUMAB, |
||||
| 1176 | 24936948 |
US |
80 | 1 |
Malignant neoplasm progression, Drug ineffective for unapproved indication, |
||||
DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, PREDNISONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 1177 | 24937118 |
JP |
69 | |
Liver disorder, Immune-mediated hepatitis, Malignant neoplasm progression, |
||||
DURVALUMAB, TREMELIMUMAB, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 1178 | 24937243 |
US |
85 | 2 |
Malignant neoplasm progression, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, LEVOTHYROXINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FLUTICASONE PROPIONATE, |
||||
| 1179 | 24937375 |
IN |
44 | 2 |
Malignant neoplasm progression, Vomiting, Decreased appetite, |
||||
| 1180 | 24937445 |
JP |
8 | 1 |
Malignant neoplasm progression, Nausea, |
||||
ZOLBETUXIMAB, |
||||
| 1181 | 24937568 |
US |
60 | 2 |
Malignant neoplasm progression, Toxicity to various agents, Autoimmune hepatitis, |
||||
NIVOLUMAB, IPILIMUMAB, DABRAFENIB, TRAMETINIB, |
||||
| 1182 | 24937616 |
US |
1 | |
Malignant neoplasm progression, General physical health deterioration, |
||||
DAROLUTAMIDE, |
||||
| 1183 | 24937738 |
US |
79 | 2 |
Malignant neoplasm progression, |
||||
LENALIDOMIDE, CALCIUM, MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE, CARISOPRODOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, MAGNESIUM, TRIAZOLAM, FAMOTIDINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, TOLTERODINE, SERTRALINE, CELECOXIB, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, |
||||
| 1184 | 24938002 |
JP |
8 | 2 |
Death, Malignant neoplasm progression, Palmar-plantar erythrodysaesthesia syndrome, |
||||
PEMBROLIZUMAB, |
||||
| 1185 | 24938094 |
CA |
69 | 1 |
Malignant neoplasm progression, Hepatic cancer stage IV, Hepatic cirrhosis, Aortic arteriosclerosis, Portal hypertension, Metastases to spine, Hepatic steatosis, |
||||
DAPAGLIFLOZIN, DAPAGLIFLOZIN, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, |
||||
| 1186 | 24938318 |
DE |
||
Metastases to skin, Myositis, Malignant neoplasm progression, Off label use, |
||||
TEBENTAFUSP, TEBENTAFUSP, MITOMYCIN, NIVOLUMAB, IPILIMUMAB, ETHIODIZED OIL, |
||||
| 1187 | 24938336 |
US |
83 | 1 |
Malignant neoplasm progression, Pruritus, Eye disorder, Diarrhoea, Haemoglobin decreased, White blood cell count decreased, Haematoma, Skin cancer, Nausea, Feeding disorder, |
||||
DASATINIB, DASATINIB, WARFARIN, |
||||
| 1188 | 24938841 |
DZ |
2 | |
Malignant neoplasm progression, |
||||
AFATINIB, |
||||
| 1189 | 24938904 |
JP |
1 | |
Malignant neoplasm progression, |
||||
LENVATINIB, PEMBROLIZUMAB, |
||||
| 1190 | 24938960 |
FR |
68 | 2 |
Pneumonia pneumococcal, Breast cancer metastatic, Metastases to bone, Metastases to lymph nodes, Malignant neoplasm progression, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, LETROZOLE, LETROZOLE TABLETS, FULVESTRANT, PALBOCICLIB, |
||||
| 1191 | 24939260 |
JP |
||
Glucagonoma, Malignant neoplasm progression, Anaemia, General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1192 | 24941691 |
61 | 2 | |
Illness, Malignant neoplasm progression, |
||||
PALBOCICLIB, |
||||
| 1193 | 24926182 |
GB |
2 | |
Death, Malignant neoplasm progression, Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, VENETOCLAX, |
||||
| 1194 | 24926306 |
GB |
1 | |
Death, Malignant neoplasm progression, Drug ineffective for unapproved indication, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, |
||||
| 1195 | 24926307 |
GB |
1 | |
Malignant neoplasm progression, Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, CYTARABINE, |
||||
| 1196 | 24926428 |
GB |
2 | |
Death, Malignant neoplasm progression, Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, VENETOCLAX, |
||||
| 1197 | 24926617 |
DE |
||
Malignant neoplasm progression, Autoimmune colitis, Cytomegalovirus infection reactivation, |
||||
INFLIXIMAB, IPILIMUMAB, METHYLPREDNISOLONE, CYCLOSPORINE, |
||||
| 1198 | 24926737 |
ES |
54 | 2 |
Skin toxicity, Hepatitis, Hypothyroidism, Malignant neoplasm progression, Rash maculo-papular, Rash, Palmar-plantar erythrodysaesthesia syndrome, Diarrhoea, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, NIVOLUMAB, NIVOLUMAB, |
||||
| 1199 | 24926827 |
GB |
2 | |
Death, Malignant neoplasm progression, Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, |
||||
| 1200 | 24927302 |
GB |
1 | |
Death, Malignant neoplasm progression, Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28